These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8639442)

  • 1. Isolation and characterization of cysteine proteinase in thrombotic thrombocytopenic purpura.
    Kelton JG; Moore JC; Warkentin TE; Hayward CP
    Br J Haematol; 1996 May; 93(2):421-6. PubMed ID: 8639442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles.
    Kelton JG; Warkentin TE; Hayward CP; Murphy WG; Moore JC
    Blood; 1992 Nov; 80(9):2246-51. PubMed ID: 1421394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura.
    Consonni R; Falanga A; Barbui T
    Br J Haematol; 1994 Jun; 87(2):321-4. PubMed ID: 7947274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura.
    Murphy WG; Moore JC; Kelton JG
    Blood; 1987 Nov; 70(5):1683-7. PubMed ID: 2822176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC; Murphy WG; Kelton JG
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic degradation of high molecular weight kininogen in acute thrombotic thrombocytopenic purpura.
    Pavord S; Kelton JG; Warner MN; Moore JC; Warkentin TE; Hayward CP
    Br J Haematol; 1997 Jun; 97(4):762-7. PubMed ID: 9217174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura.
    Falanga A; Consonni R; Ruggenenti P; Barbui T
    Br J Haematol; 1991 Nov; 79(3):474-80. PubMed ID: 1751375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura.
    Zeigler ZR; Kelton JG; Moore JC; Shadduck RK; Andrews DF; Nath R; Agha M
    Bone Marrow Transplant; 1999 Sep; 24(6):641-5. PubMed ID: 10490730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The platelet aggregating factor(s) of thrombotic thrombocytopenic purpura.
    Kelton JG; Moore JC; Murphy WG
    Prog Clin Biol Res; 1990; 337():141-9. PubMed ID: 2191308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura.
    Murphy WG; Moore JC; Barr RD; Pai MK; Kelton JG
    Br J Haematol; 1987 Aug; 66(4):509-13. PubMed ID: 3499167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.
    Lian EC; Mui PT; Siddiqui FA; Chiu AY; Chiu LL
    J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Purification and some properties of platelet aggregating protein (PAP) from the plasma of a patient with thrombotic thrombocytopenic purpura].
    Chen SH
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):382-4, 28. PubMed ID: 2598093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma.
    Lian EC; Harkness DR; Byrnes JJ; Wallach H; Nunez R
    Blood; 1979 Feb; 53(2):333-8. PubMed ID: 570069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-agglutinating protein p37 from a patient with thrombotic thrombocytopenic purpura has characteristics similar to prethrombin 2.
    Kim SH; Park SJ; Lee JW; Jin JY
    J Biochem Mol Biol; 2002 Sep; 35(5):524-31. PubMed ID: 12359097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease.
    Delmas Y; Helou S; Chabanier P; Ryman A; Pelluard F; Carles D; Boisseau P; Veyradier A; Horovitz J; Coppo P; Combe C
    BMC Pregnancy Childbirth; 2015 Jun; 15():137. PubMed ID: 26081109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelets-morphology, shape changing factor, and platelet agglutinating factor. TTP Research Group].
    Hattori A; Tatewaki W; Fuse I; Shibata A
    Nihon Rinsho; 1993 Jan; 51(1):122-8. PubMed ID: 8433504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation in patients with thrombotic thrombocytopenic purpura.
    Hoffman M; Monroe DM; Roberts HR
    Am J Hematol; 1993 Feb; 42(2):182-5. PubMed ID: 7679878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
    Tandon NN; Rock G; Jamieson GA
    Br J Haematol; 1994 Dec; 88(4):816-25. PubMed ID: 7529543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura.
    Wright JF; Wang H; Hornstein A; Hogarth M; Mody M; Garvey MB; Blanchette V; Rock G; Freedman J
    Br J Haematol; 1999 Dec; 107(3):546-55. PubMed ID: 10583256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.